Kinetic of in vitro generation of some hemorphins: Early release of LVV-hemorphin-7, precursor of VV-hemorphin-7

Neuropeptides

Volumn 30, Issue 1, 1996, Pages 1-5

  Dagouassat, N ^a   Garreau, I ^a   Zhao, Q ^a   Sannier, F ^a   Piot, J M ^a,b  

^a Pôle Sciences et Technologies   (France)

^b Pole Sciences et Technologies   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; HEMORPHIN 7; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CATTLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACIDS; ANIMALS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLOBINS; HEMOGLOBINS; HYDROLYSIS; KINETICS; PEPTIDE FRAGMENTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0029874625     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90047-5     Document Type: Article

References (33)

1. Silk, D. B. A., Marrs, T. C., Addison, J. M., Burston, D., Clark, M. L. and Matthews, D. M. Absorption of amino acids from an amino acid mixture simulating casein and a tryptic hydrolysate of casein in man. Clin. Sci. Mol. Med. 1973; 45: 715-719.
2. Dive, D., Piot, J. M., Sannier, R, Guillochon, D., Charet, P. and Lutrat, S. Use of hemoglobin enzymic hydrolysates, prepared on a pilot-plant scale, as a nitrogen source for the cultivation of three species of Tetrahymena. Enzyme Microb. Technol. 1989; 11: 165-169.
3. Zioudrou, C., Streaty, R. A. and Klee, W. A. Opioid peptides derived from food proteins. J. Biol. Chem. 1979; 254: 2446-2449.
4. Brantl, V., Teschemacher, H., Henschen, A. and Lottspeich, F. Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Z. Physiol. Chem. 1979; 360: 1211-1216.
5. Loukas, S., Varoucha, D., Zioudrou, C., Streaty, R. A. and Klee, W. A. Opioid activities and structures of a -casein-derived exorphins. Biochemistry 1983; 22: 4567-4573.
6. Brantl, V. Novel opioid peptides derived from human β-casein: human β-casomorphins. Eur. J. Pharmacol. 1985; 106: 213-214.
7. Fiat, A. M. and Jolles, P. Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects. Mol. Cell. Biochem. 1989; 87: 5-30.
8. Burger, E. Peptides hormones and neuropeptides. Arzneim.-Forsch.-Drug Res. 1988; 38: 754-761.
9. Brantl, V., Gramsch, C., Lottspeich, R, Henschen, A., Jaeger, K. H. and Herz, A. Novel opioid peptides derived from mitochondrial cytochromeb: cytochrophins. Eur. J. Pharmacol. 1985; 111: 293-294.
10. Brantl, V., Gramsch, C., Lottspeich, F., Mertz, R., Jaeger, K. H. and Herz, A. Novel opioid peptides derived from haemoglobin: hemorphins. Eur. J. Pharmacol. 1986; 125: 309-310.
11. Brantl, V., Teschemacher, H., Bläsig, J., Henschen, A. and Lottspeich, R Opioid activities of β-casomorphins. Life Sci. 1981; 28: 1903-1909.
12. Yukhananov, R. Y., Glämsta, E. V. and Nyberg, F. Interaction of hemorphins with opioid receptors in the rat vas deferens and guinea-pig ileum. Regul. Pept. 1994; Suppl. 1 : S239-S242.
13. Kosterlitz, H. W. and Watt, A. J. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br. J. Pharmacol. Chemother. 1968; 33: 266-276.
14. Glämsta, E. V., Marklund, A., Hellman, U., Wernstedt, C., Terenius, L. and Nyberg, R Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul. Pept. 1991; 34: 169-179.
15. Piot, J. M., Zhao, Q., Guillochon, D., Ricart, G. and Thomas, D. Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolysate. Biochem. Biophys. Res. Commun. 1992; 189: 101-110.
16. Glämsta, E. V., Meyerson, B., Silberring, J., Terenius, L. and Nyberg, F. Isolation of hemoglobin-derived opioid peptide from cerebrospinal fluid of patients with cerebrovascular bleedings. Biochem. Biophys. Res. Commun. 1992; 184: 1060-1066.
17. Lantz, I., Glämsta, E. V., Talbäck, L. and Nyberg, F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEES Lett. 1991; 287: 39-41.
18. Zhao, Q., Sannier, F., Garreau, I., Guillochon, D. and Piot, J. M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem. Biophys. Res. Commun. 1994; 204: 216-223.
19. Scheffler, H., Koch, G., Brantl, V. and Teschemacher, H. Release of opioid peptide immunoreactive materials from pituitary tissue upon stimulation with a hemoglobin fragment, hemorphin-4, in vitro. In: Van Ree, J. M., Mulder, A. H., Wiegant, V. M. and Van Wimersma Greidanus T. B., eds. News leads in opioid research. Amsterdam: Elsevier; 1990: 379-380.
20. Garreau, I., Zhao, Q., Pejoan, C., Cupo, A. and Piot, J. M. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides. Neuropeptides 1995; 28: 243-250.
21. Zhao, Q., Sannier, F., Ricart, G. and Piot, J. M. A rapid detection and identification of hemorphins released from bovine hemoglobin enzymatic hydrolysis by use of HPLC coupled with photodiode array detector. J. Liq. Chromatogr. 1995; 18: 93-103.
22. Adler-Nissen, J. Control of the proteolytic reaction and the level of bitterness in protein hydrolysis processes. J. Chem. Technol. Biotechnol. 1984; 34B: 215-222.
23. Adler-Nissen, J. Determination of the degree of hydrolysis of food protein hydrolysates by the trinitrobenzene sulfonic acid. J. Agric. Food Chem. 1979; 27: 1256-1262.
24. Bindlingmeyer, B. A., Cohen, S. A., Tarvin, T. L., Napier, J. R. and Hancock, W. S. Rapid analysis of amino acids using pre-column derivation. J. Chromatogr. 1984; 336: 93-104.
25. Davis, T. P. Gillespie, T. J. and Porreca, F. Peptide fragments derived from the β-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides 1989; 10: 747-751.
26. Davis, T. P., Porreca, F., Burks, T. F. and Dray, A. The proenkephalin A fragment, peptide E: central processing and CNS activity in vivo. Eur. J. Pharmacol. 1985; 111: 177-184.
27. Giros, B., Gros, C., Llorens-Cortes, C. and Schwanz, J. C. Enképhalines, autres opioides endogènes et motricité digestive. Les peptides opioides: métabolisme et récepteurs. Gastroenterol. Clin. Biol. 1987; 11: 7B-13B.
28. Glämsta, E. V., Mòrkid, L., Lantz, I. and Nyberg, F. Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and β-endorphin following long distance running. Regul. Pept. 1993; 49: 9-18.
29. Carraway, R. E., Mitra, S. P. and Cochrane, D. E. Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J. Biol. Chem. 1987; 262: 5968-5973.
30. Carraway, R. E., Mitra, S. P. and Ferris, C. F. Pepsin treatment of mammalian plasma generate immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations. Endocrinology 1986; 119: 1519-1526.
31. Carraway, R. E. Rapid proteolytic generation of neurotensin-related peptide(s) and biologic activity during extraction of rat and chicken gastric tissues.;. Biol. Chem. 1984; 259: 10328-10334.
32. Carraway, R. E. and Feurle, G. E. Generation of xenopsin-related peptides during acid extraction of gastric tissues. J. Biol. Chem. 1985; 260: 10921-10925.
33. Barkhudaryan, N., Kellermann, J., Galoyan, A. and Lottspeich, F. High molecular weight aspartic endopeptidase generates a coronaro-constrictory peptide from the β-chain of hemoglobin. FEES Lett. 1993; 329: 215-218.